Costas G. Xydias

What Costas G. Xydias does

Costas G. Xydias S.A. (ΦΑΡΜΑΚΑΠΟΘΗΚΗ Κ.ΞΥΔΙΑΣ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ) is a family-owned pharmaceutical wholesale distributor founded in 1983 in Athens, Greece by Konstantinos Xydias, operating from a single headquarters at Solomou 65. The company functions as a wholesale pharmaceutical warehouse distributing prescription drugs, over-the-counter medicinal products, parapharmaceuticals (including diagnostics and pediatric cosmetics), pharmaceutical cosmetics, veterinary medications, nutritional supplements, and medical devices to retail pharmacies and pharmaceutical wholesalers throughout Greece. The company holds exclusive distribution agreements in Greece with three multinational pharmaceutical manufacturers: Amdipharm Mercury Company Limited (AMCo), Bausch & Lomb, and Riemser AG, and has maintained international sourcing relationships with major European pharmaceutical houses since 1984.

The company's core technology asset is a B2B e-commerce ordering platform launched at b2b.xydias.gr in January 2018, enabling pharmacists to place orders digitally by product name or unique product code. The firm holds ISO 9001:2015 certification covering the trading and distribution of Medical Technology Products and is listed in the official National Organization for Medicines (EOF) catalogue. Operations are concentrated at the Athens headquarters with 11-50 employees; the company reports a 40% expansion of its distribution network since 2016 and 20% staff growth over the past four years.

The business model is a B2B wholesale distribution model that generates transaction-based revenue through resale of drugs and healthcare products to retail pharmacies (SMB segment) and wholesale buyers (enterprise segment). Pricing is quote-based and not publicly disclosed, with transactions executed through the B2B online platform and direct field sales. The go-to-market combines direct field sales with the digital ordering platform, supported by marketing through the corporate website, the EOF catalogue listing, and email newsletters. Geographic scope is primarily domestic Greece despite long-standing international supplier relationships.

Name

Costas G. Xydias

Legal name

ΦΑΡΜΑΚΑΠΟΘΗΚΗ Κ.ΞΥΔΙΑΣ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ

Website

https://xydias.gr

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Short description

Costas G. Xydias is a family-owned Greek pharmaceutical wholesaler founded in 1983, distributing prescription medicines, parapharmaceuticals, cosmetics, and medical devices to pharmacies and wholesale buyers across Greece via exclusive multinational partnerships and a B2B ordering platform.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

OTC & Consumer Health Distributors (HLAIAJAC)

Keywords

• Pharmaceutical wholesale distribution
• Medicines and OTC supply
• Parapharmaceutical products
• B2B pharmacy ordering
• Medical device distribution

Headquarters

HQ city

Solomoú

HQ country

Greece

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Wholesale Distribution: Revenue generated through wholesale distribution of drugs, over-the-counter medicinal products, and cosmetics to pharmacies and pharmaceutical wholesalers throughout Greece. The company holds exclusive distribution agreements with multinational partners including Amdipharm Mercury Company Limited (AMCo), Bausch & Lomb, and Riemser AG.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Costas G. Xydias S.A. is a pharmaceutical wholesaler that distributes prescription medications, over-the-counter (OTC) medicinal products, parapharmaceuticals (diagnostics and pediatric cosmetics), pharmaceutical cosmetics, veterinary medications, nutritional supplements, and medical devices to retail pharmacies and pharmaceutical wholesalers across Greece. The company supplements its physical wholesale operations with a B2B e-shop platform (b2b.xydias.gr) that allows pharmacists to place orders online by product name or unique code, supported by exclusive distribution agreements with multinational partners such as AMCo, Bausch & Lomb, and Riemser AG.

Product overview

Costas G. Xydias S.A. is a family-owned pharmaceutical wholesaler founded in 1983, operating as a single integrated business rather than a platform with modules. The core offering is pharmaceutical distribution services, comprising wholesale distribution of medications, parapharmaceutical products (diagnostics and pediatric cosmetics), pharmaceutical cosmetics, veterinary medications, nutritional supplements, and medical devices to pharmacies and wholesalers throughout Greece. The company also provides an e-shop/B2B online ordering platform for pharmacists to place orders digitally. Distribution is handled through an organized network with exclusive agreements for certain multinational partners (AMCo, Bausch & Lomb, Riemser AG).

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Distribution Services Wholesale distribution of prescription medications, over-the-counter medicinal products, parapharmaceuticals, cosmetics, veterinary medications, nutritional supplements, and medical devices to retail pharmacies and pharmaceutical wholesalers throughout Greece.
• B2B Online Ordering Platform (e-shop) Online B2B e-shop platform (b2b.xydias.gr) that enables pharmacists to place wholesale pharmaceutical orders digitally, with products searchable by name or unique product code.

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core.

• Amdipharm Mercury Company Limited (AMCo)coreStrategic or Co-development PartnerExclusive distribution agreement for product distribution. The company has established stable and loyal relationships with partners at home and abroad, governed by trust, security, respect and reliability.
• Bausch & LombcoreStrategic or Co-development PartnerExclusive distribution agreement for pharmaceutical products. As one of the first Greek pharmaceutical wholesalers since 1984, the company has developed relationships with prominent firms throughout Europe.
• Riemser AGcoreStrategic or Co-development PartnerExclusive distribution agreement secured with this multinational pharmaceutical company. The company maintains exclusive agreements with select multinational partners for product distribution across Greece.

Scale indicators6 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• PHOENIX Group: PHOENIX Group is one of Europe's largest pharmaceutical wholesale distributors, operating across more than 25 countries with a B2B distribution model serving pharmacies. It is the closest direct analog to Xydias in business model and customer base, though at significantly larger scale.
• Alliance Healthcare: Alliance Healthcare (a division of Walgreens Boots Alliance) operates pharmaceutical wholesale and distribution across Europe, supplying pharmacies, hospitals, and manufacturers. It mirrors Xydias's B2B pharma distribution model and exclusive supplier agreements, with broader geographic reach.
• Quantum Pharma (UK): Quantum Pharma is a UK-based pharmaceutical distributor and manufacturer specializing in supply of unlicensed medicines, specials, and niche pharmaceuticals. Comparable to Xydias for its regulated, niche pharmaceutical distribution focus.

Broad incumbents

• Cencora: Cencora (formerly AmerisourceBergen) is one of the largest global pharmaceutical wholesalers and distributors, serving pharmacies, hospitals, and manufacturers worldwide. Relevant to Xydias as the dominant incumbent in the same pharmaceutical distribution category at vastly larger scale.
• Cardinal Health: Cardinal Health is a major US-headquartered pharmaceutical and medical product distributor serving retail pharmacies, hospitals, and healthcare systems. Relevant as a broad incumbent competitor in pharmaceutical wholesale with overlapping customer base.
• McKesson: McKesson is a leading global pharmaceutical wholesale distributor and healthcare services company. Comparable to Xydias in core pharma distribution activity but operates at global scale with much broader product and service portfolios.

Regional players

• Profarma (Poland): Profarma is a pharmaceutical wholesaler serving the Polish market, distributing drugs and parapharmaceuticals to pharmacies. It is comparable to Xydias as a single-country pharma wholesaler with a similar product mix and pharmacy customer base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/CostasGxydiasSA
• LinkedInlinkedin.com/company/costasxydiassa

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Costas G. Xydias